T J Allen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T J Allen

Showing results (81-90 of 97) with videos related to

Pageof 10

Sort By:

Current Pharmaceutical Design|September 28, 2007

PPARs and diabetes-associated atherosclerosisA C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.

Drug and Alcohol Dependence|March 14, 1997

Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjectsF G Moeller, D M Dougherty, T Rustin, et al.

Hypertension (Dallas, Tex. : 1979)|October 17, 1998

Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitusT Tikkanen, I Tikkanen, M D Rockell, et al.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2001

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuriaG Jerums, T J Allen, D J Campbell, et al.

Diabetologia|December 3, 2003

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive ratB J Davis, J M Forbes, M C Thomas, et al.

Diabetologia|July 3, 2003

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathyB J Davis, C I Johnston, L M Burrell, et al.

Circulation Research|February 10, 2000

Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetesR E Gilbert, J R Rumble, Z Cao, et al.

Circulation Research|January 11, 2000

Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibitionK Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004

Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuriaG Jerums, T J Allen, D J Campbell, et al.

Diabetologia|August 18, 2001

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockadeS A Mifsud, T J Allen, J F Bertram, et al.

Pageof 10

Search research articles

Showing results (81-90 of 97) with videos related to

Sort By:

Pageof 10

Current Pharmaceutical Design|September 28, 2007

PPARs and diabetes-associated atherosclerosisA C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.

Drug and Alcohol Dependence|March 14, 1997

Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjectsF G Moeller, D M Dougherty, T Rustin, et al.

Hypertension (Dallas, Tex. : 1979)|October 17, 1998

Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitusT Tikkanen, I Tikkanen, M D Rockell, et al.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2001

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuriaG Jerums, T J Allen, D J Campbell, et al.

Diabetologia|December 3, 2003

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive ratB J Davis, J M Forbes, M C Thomas, et al.

Diabetologia|July 3, 2003

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathyB J Davis, C I Johnston, L M Burrell, et al.

Circulation Research|February 10, 2000

Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetesR E Gilbert, J R Rumble, Z Cao, et al.

Circulation Research|January 11, 2000

Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibitionK Jandeleit-Dahm, K M Hannan, C A Farrelly, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004

Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuriaG Jerums, T J Allen, D J Campbell, et al.

Diabetologia|August 18, 2001

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockadeS A Mifsud, T J Allen, J F Bertram, et al.

Pageof 10